Microelectrode Array Stem Cell Assay for Toxicity Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current in vitro toxicity testing methods for pharmaceuticals and chemicals are inefficient, requiring large numbers of animals and failing to detect all toxicities, leading to high costs and uncertainties in drug development, with existing assays being limited by inhomogeneous cell populations and poor detection methods.
Innovation Solution
A functional tissue assay system using substrate-integrated multi-functional microelectrode arrays (MEA) to cultivate and analyze embryonic stem cell-derived tissues, allowing for the measurement of electrical activity and other parameters in response to test substances, providing a more reliable and efficient alternative to animal testing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional in vitro toxicity testing methods are used, then animal testing can be performed, but the detection precision and reliability of toxicity assessment deteriorates due to inhomogeneous cell populations and poor detection methods
Solution Approach 1:
The patent segments the homogeneous cell population by using microelectrode arrays to individually address and measure electrical activity of single cells or small cell groups, rather than measuring bulk tissue activity. This segmentation enables precise detection of toxicity effects on individual cells while maintaining population homogeneity through stem cell-derived uniform cell types.
Solution Approach 2:
The patent replaces traditional mechanical and chemical toxicity assessment methods with electrical field-based detection using microelectrode arrays. By measuring electrical activity (action potentials, field potentials) of cells, the system achieves non-invasive, real-time toxicity detection with high precision, substituting conventional less-precise methods.
2Reliability
If comprehensive toxicity testing is performed on multiple species, then the coverage of toxicity detection improves, but the cost and time consumption increases significantly
Solution Approach 1:
The patent creates a universal toxicity testing platform using stem cell-derived cells that can model multiple tissue types and species-specific responses in a single system. The microelectrode array-based electrical activity detection provides a multi-functional assessment tool that can evaluate cardiotoxicity, neurotoxicity, and other toxicities simultaneously, replacing the need for multiple species-specific tests.
Solution Approach 2:
The patent performs preliminary toxicity screening using the stem cell-based in vitro model before proceeding to animal testing and clinical trials. By conducting comprehensive toxicity assessment early in drug development using this high-throughput electrical activity detection system, potentially toxic compounds are identified and eliminated before time-consuming animal studies and clinical trials.
3Ease of manufacture
If traditional in vitro assays with primary cell cultures are used, then the preparation can be performed, but the labor intensity and complexity increase due to laborious preparations and variation between individual animals
Solution Approach 1:
The patent changes the fundamental parameter of cell population homogeneity by using stem cell-derived cells instead of primary cell cultures from individual animals. This parameter change eliminates biological variation between donors and simplifies preparation procedures, as stem cell-derived cells can be expanded and standardized in culture before assay implementation.
Solution Approach 2:
The patent employs stem cells that can self-renew and self-differentiate into uniform cell populations under controlled culture conditions. This self-service capability eliminates the need for complex tissue dissociation, cell isolation, and individual animal sampling procedures required by primary cell cultures, significantly reducing preparation labor and complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables reliable and cost-effective toxicity testing and drug development by using embryonic stem cell-derived tissues on MEAs, reducing the need for animal testing and improving the detection of toxicities, thereby streamlining the development process.
Implementation Method 1
measuring electrical activity of said biological material through said electrode array
Data Source
AI summary
Provided are functional cell and tissue assay systems based on substrate-integrated multifunctional microelectrode arrays implementing stem cell technology. The system covers normal and pathogenic characteristics.